# FDA Approves Generic Fluorouracil Intravenous Formulation The FDA approved Eugia US LLC's abbreviated new drug application for generic fluorouracil intravenous injection on July 17, 2012, expanding treatment options for cancer patients and potentially reducing medication costs in the oncology market. The approval of this generic version of the widely-used chemotherapy drug is expected to increase competitive pricing pressure and improve patient access to this critical cancer therapeutic.